Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04857073 · ClinicalTrials.gov registry record · NA
Daily Versus Every Other Day Glucose Monitoring in Gestational Diabetes Mellitus
A NA study, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- NA
- Development phase
- 200
- Enrollment target
NCT04857073 is a NA study that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 200 participants.
The verdict
NCT04857073, a NA study, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
Study Summary
Gestational diabetes mellitus (GDM) occurs secondary to carbohydrate intolerance in pregnancy. Screening of GDM occurs between 24 to 28 weeks gestation by a screening 1-hour 50g glucose challenge test and confirmed with a 100g 3-hour fasting glucose tolerance test. Once patients are diagnosed with GDM, they are instructed to check their fingerstick blood glucose four times daily, every day. There is insufficient evidence to determine the ideal frequency and timing of glucose monitoring in patients diagnosed with GDM and no absolute guidelines put in place by the American College of Obstetricians and Gynecologists (ACOG). The study team aims to confirm non inferiority on the patient population on the effects of daily (4x daily) versus every other day (4x daily) glucose monitoring in all patients diagnosed with GDM.
Interventions
- OTHER Glucose Monitoring
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2021-04-10 |
| Est. Completion | 2022-04-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04857073
The ClinicalTrials.gov registry entry for NCT04857073 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Glucose Monitoring is the first listed.
NCT04857073 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04857073 about?
NCT04857073 is a clinical study titled "Daily Versus Every Other Day Glucose Monitoring in Gestational Diabetes Mellitus". Gestational diabetes mellitus (GDM) occurs secondary to carbohydrate intolerance in pregnancy. Screening of GDM occurs between 24 to 28 weeks gestation by a screening 1-hour 50g glucose challenge test and confirmed with a 100g 3-hour fasting glucose tolerance test. Once patients are diagnosed with G...
What is the current status of trial NCT04857073?
This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2021-04-10. Estimated completion is 2022-04-06.
What interventions are being tested in trial NCT04857073?
The interventions under investigation include: Glucose Monitoring (OTHER).
Who is sponsoring clinical trial NCT04857073?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.